Maze Therapeutics (MAZE) Capital Expenditures (2024 - 2026)
Maze Therapeutics (MAZE) reported Capital Expenditures of $93000.0 for Q1 2026, down 68.9% on a YoY basis from $299000.0 in Q1 2025, and down 87.76% sequentially from $760000.0 in Q4 2025.
Maze Therapeutics (MAZE) Capital Expenditures (2024 - 2026) Analysis & Trends
Maze Therapeutics (MAZE) has 3 years of Capital Expenditures data on file, last reported at $93000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 68.9% year-over-year to $93000.0; the trailing twelve-month figure through Mar 2026 stood at $588000.0 (down 49.61% YoY), and the FY2025 full-year result was $794000.0, down 30.78% from the prior year.
- Capital Expenditures slipped to $93000.0 in Q1 2026, from $760000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $939000.0 in Q4 2024 to a low of -$658000.0 in Q3 2025.
- A 3-year average of $226000.0 and a median of $279000.0 in 2024 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 259.11% in 2025, while the deepest fall reached 473.86% in 2025.
- Tracing MAZE's Capital Expenditures over 3 years: stood at $939000.0 in 2024, then declined by 19.06% to $760000.0 in 2025, then sank by 87.76% to $93000.0 in 2026.
- Business Quant data shows MAZE's Capital Expenditures at $93000.0 in Q1 2026, $760000.0 in Q4 2025, and -$658000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Maze Therapeutics | 1.49 Bn | 1.49 Bn | 18.21 Mn | 93,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93,000.00 |
| Mar 31, 2026 | 93,000.00 |
| Dec 31, 2025 | 760,000.00 |
| Dec 31, 2025 | 760,000.00 |
| Sep 30, 2025 | -658,000.00 |
| Sep 30, 2025 | -658,000.00 |
| Jun 30, 2025 | 393,000.00 |
| Jun 30, 2025 | 393,000.00 |
| Mar 31, 2025 | 299,000.00 |
| Mar 31, 2025 | 299,000.00 |
| Dec 31, 2024 | 939,000.00 |
| Dec 31, 2024 | 939,000.00 |
| Sep 30, 2024 | 176,000.00 |
| Sep 30, 2024 | 176,000.00 |
| Jun 30, 2024 | -247,000.00 |
| Jun 30, 2024 | -247,000.00 |
| Mar 31, 2024 | 279,000.00 |
| Mar 31, 2024 | 279,000.00 |